Skip to main content
SpringerLink
Log in

Facing the enigma of immunomodulatory effects of intravenous immunoglobulin

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Intravenous immunoglobulin (IVIg) is a safe remedy for a number of conditions; it is produced from human plasma of thousands of healthy donors. The therapeutic effect of IVIg lies within its content. IVIg contains natural antibodies, which are more polyreactive than immune antibodies, including immunoglobulin G antibodies against endogenous and exogenous antibodies, immunomodulating peptides, and varies cytokines.

Beneficial effects of IVIg have been established in immunodeficiencies, as well as in some autoimmune diseases. Also, numerous therapeutic effects of IVIg have been reported over the years in varies autoimmune diseases, recurrent pregnancy loss, and cancer.

Many proposed immunoregulatory mechanisms of action of IVIg have been suggested. Some of them have been proven, others are still an enigma, at least in part. Some of these mechanisms entail (a) Fc-receptor blockade; (b) neutralization of pathogenic autoantibodies via idiotypic and anti-idiotypic antibodies; (c) effects on the Fas apoptotic pathway via agonistic and antagonistic anti-Fas autoantibodies; (d) regulation of complement components; (e) modulation of cytokine secretion; (f) hindrance of natural-killer cell activity; (g) inhibition of matrix metalloproteinase-9; (h) suppression of NFkB activation and IkB degradation; (i) G1 cell cycle arrest; (j) prevention of tumor growth; (k) decrease in leukocyte recruitment; (l) attenuation of T-cell stimulation; (m) effects on antibody kinetics; and (n) effects on dendritic cells.

The variant mechanisms of IVIg are believed to cooperate in a synergistic way, which all together point to IVIg as a therapeutic preparation with anti-inflammatory, antiself-reactivity, antimetastatic, and embryo-protective effects.

This article reviews several main mechanisms of IVIg in order to shed some light on the set of therapeutic effects of IVIg, which are not yet fully understood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fishman, P., Bar-Yehuda, S., and Shoenfeld, Y. (2004), Int J Oncol 21, 875–880.

    Google Scholar 

  2. Kazatchkine, M. D. and Kaveri, S. V. (2001), N Engl J Med 345, 747–755.

    Article  PubMed  CAS  Google Scholar 

  3. Dalakas, M. C. (1997), Ann Intern Med 126, 721–730.

    PubMed  CAS  Google Scholar 

  4. MRC Working Party on Hypogammaglobulinaemia. Hypogammaglobulinaemia in the United Kingdom. London: Her Majesty’s Stationery Office, 1971.

  5. Marinos, C., Dalakas, M. C., and Spath, P. J. In: Marinos, C., Dalakas, M. C., Spath, P. J., eds. Intravenous Immunoglobulins in the Third Millennium. New York/London: Parthenon Publishing Group, 2004, pp. 1–409.

    Google Scholar 

  6. Segal, E, and Shoenfeld, Y. (2001), Harefuah 140, 955–958.

    PubMed  CAS  Google Scholar 

  7. Shoenfeld, Y. and Krause, I. (2004), J Clin Immunol 24, 107–114.

    Article  PubMed  CAS  Google Scholar 

  8. Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., and Unkeless, J.C. (1986), N Engl J Med 314, 1236–1239.

    Article  PubMed  CAS  Google Scholar 

  9. Debre, M., Bonnet, M. C., Fridman, W. H., et al. (1993), Lancet 342, 945–949.

    Article  PubMed  CAS  Google Scholar 

  10. Bar-Dayan, Y., Kaveri, S. V., Bar-Dayan, Y., Pashov A., Shoenfeld, Y., and Kazatchkine, M. D., (In Eibl, M. and Huber H., eds. Anti-Inflammatory Effects of Intravenous Immunoglobulin (IVIg) in Symposium in Immunology. VII. Heidelberg: Springer-Verlag, 2002, pp. 171–184.

    Google Scholar 

  11. Samuelsson, A., Towers, T. L., Ravetch, J. V. (2001), Science 291, 484–486.

    Article  PubMed  CAS  Google Scholar 

  12. Ichiyama, T., Ueno, Y., Hasegawa, M., Ishikawa, Y., Matsubara, T., and Furukawa, S. (2005), Rheumatology (Oxford) 44, 314–317.

    Article  CAS  Google Scholar 

  13. Kurlander, R.J. and Hall, J. (1986), J Clin Invest 77, 2010–2018.

    PubMed  CAS  Google Scholar 

  14. Kurlander, R. J. (1980), J Clin Invest 66, 773–781.

    PubMed  CAS  Google Scholar 

  15. Yu, Z. and Lennon, V. A. (1999), N Engl J Med 340, 227–228.

    Article  PubMed  CAS  Google Scholar 

  16. Braun-Moscovici, Y. and Furst, D. E. (2003), Curr Opin Rheumatol 15, 237–245.

    Article  PubMed  Google Scholar 

  17. van Koningsveld, R., Schmitz, P. I., Meche, F. G., Visser, L. H., Meulstee, J., van Doorn, P. A.; Dutch GBS Study Group. (2004), Lancet. 363, 192–196.

    Article  PubMed  CAS  Google Scholar 

  18. Krause, I., Hacham, S., Gilburd, B., Damianovitch, M., Blank, M., and Shoenfeld, Y. (1995), Clin Immunol Immunopathol 77, 229–235.

    Article  PubMed  CAS  Google Scholar 

  19. Levy, Y., Sherer, Y., Ahmed, A., et al. (1998), Nat Immun 16, 207–214.

    Article  PubMed  CAS  Google Scholar 

  20. Dalakas, M. C., Spath, P. J., eds. (2004), Intravenous Immunoglobulin in the Third Millennium. New York/London: Parthenon Publishing Group.

    Google Scholar 

  21. Rossi, F., Sultan, Y., and Kazatchkine, M. D. (1988), Clin Exp Immunol 74, 311–316.

    PubMed  CAS  Google Scholar 

  22. Shoenfeld, Y., Rauova, L., Gilburd, B., et al. (2002), Int Immunol 14, 1303–1311.

    Article  PubMed  CAS  Google Scholar 

  23. Krause, I., Blank, M., Sherer, Y., Gilburd, B., Kvapil, F., and Shoenfeld, Y. (2002), Eur J Immunol 32, 3414–3424.

    PubMed  CAS  Google Scholar 

  24. Shoenfeld, Y. and Katz, U. (2005), Autoimmunity 38, 123–137.

    Article  PubMed  CAS  Google Scholar 

  25. Altznauer, F., von Gunten, S., Spath, P., and Simon, H. U. (2003), J Allergy Clin Immunol 112, 1185–1190.

    Article  PubMed  CAS  Google Scholar 

  26. Prasad, N. K., Papoff, G., Zeuner, A., et al. (1998), J Immunol 161, 3781–3790.

    PubMed  CAS  Google Scholar 

  27. Viard, I., Wehrli, P., Bullani, R., et al. (1998), Science 282, 490–493.

    Article  PubMed  CAS  Google Scholar 

  28. Basta, M. and Dalakas, M. C. (1994), J Clin Invest 94, 1729–1735.

    Article  PubMed  CAS  Google Scholar 

  29. Lutz, H. U., Stammler, P., Jelezarova, E., Nater, M., and Spath, P. J. (1996), Blood 88, 184–193.

    PubMed  CAS  Google Scholar 

  30. Sherer, Y., Wu, R., Krause, I., et al. (2001), Hum Antibodies 10, 51–53.

    PubMed  CAS  Google Scholar 

  31. Svenson, M., Bagge Hansen, M., and Bendtzen, K. (1990), Scand J Immunol 32, 695–701.

    Article  PubMed  CAS  Google Scholar 

  32. Bendtzen, K., Svenson, M., Jonsson, V., and Hippe, E. (1990), Immunol Today 11, 167–169.

    Article  PubMed  CAS  Google Scholar 

  33. Amran, D., Renz, H., Lack, G., Bradley, K., and Gelfand, E. W. (1994), Clin Immunol Immunopathol 73, 180–186.

    Article  PubMed  CAS  Google Scholar 

  34. Toungouz, M., Denys, C., and Dupont, E. (1996), Transplantation 62, 1292–1296.

    Article  PubMed  CAS  Google Scholar 

  35. Warrington, R. J. (1998), J Rheumatol 15, 616–620.

    Google Scholar 

  36. Ahmed, K., Vianna, J. L., Khamashta, M. A., and Hughes, G. R. (1992), Clin Exp Rheumatol 10, 503.

    PubMed  CAS  Google Scholar 

  37. Kwak, J. Y., Kwak, F. M., Ainbinder, S. W., Ruiz, A. M., and Beer, A. E. (1996), Am J Reprod Immunol 35, 363–369.

    PubMed  CAS  Google Scholar 

  38. Nachbaur, D., Herold, M., Eibl, B., et al. (1997), Immunology 90, 212–218.

    Article  PubMed  CAS  Google Scholar 

  39. Noh, G. W., Lee, W. G., Lee, W., and Lee, K. (1998), Immunol Lett 62, 19–24.

    Article  PubMed  CAS  Google Scholar 

  40. Leung, D. Y., Cotran, R. S., Kurt-Jones, E., Burns, J. C., Newburger, J. W., and Pober, J. S. (1989), Lancet 2, 1298–1302.

    Article  PubMed  CAS  Google Scholar 

  41. Sharief, M. K., Ingram, D. A., Swash, M., and Thompson, E. J. (1999), Neurology 52, 1833–1838.

    PubMed  CAS  Google Scholar 

  42. Blank, M., Levy, Y., Amital, H., Shoenfeld, Y., Pines, M., and Genina, O. (2002), Arthritis Rheum 46, 1689–1690.

    Article  PubMed  CAS  Google Scholar 

  43. Reinhold, D., Perlov, E., Schrecke, K., Kekow, J., Brune, T., and Sailer, M. (2004), J Neuroimmunol 152, 191–194.

    Article  PubMed  CAS  Google Scholar 

  44. Shoenfeld, Y and Fishman, P. (1999), Int Immunol 11, 1247–1252.

    Article  PubMed  CAS  Google Scholar 

  45. King, A. and Loke, Y. W. (1990), Cell Immunol 129, 435–448.

    Article  PubMed  CAS  Google Scholar 

  46. Abe, Y., Horiuchi, A., Miyake, M., and Kimura, S. (1994), Immunol Rev 139, 5–19.

    Article  PubMed  CAS  Google Scholar 

  47. Blidaru, I., Cianga, C., and Slatineanu, S. (2001), Rev Med Chir Soc Med Nat Iasi 105, 19–22.

    PubMed  CAS  Google Scholar 

  48. Shapiro, S., Shoenfeld, Y., Gilburd, B., Sobel, E., and Lahat, N. (2002), Cancer 95, 2032–2037.

    Article  PubMed  CAS  Google Scholar 

  49. Ronda, N., Leonardi, S., Orlandini, G., et al. (1999), J Autoimmun 13, 121–127.

    Article  PubMed  CAS  Google Scholar 

  50. Senzaki, H., Masutani, S., Kobayashi, J., et al. (2001), Circulation 104, 860–833.

    Article  PubMed  CAS  Google Scholar 

  51. Baldwin, A. S. Jr. (1996), Annu Rev Immunol 14, 649–683.

    Article  PubMed  CAS  Google Scholar 

  52. Ichiyama, T., Ueno, Y., Isumi, H., Niimi, A., Matsubara, T., and Furukawa, S. (2004), Inflamm Res 53, 253–256.

    Article  PubMed  CAS  Google Scholar 

  53. Furukawa, S., Matsubara, T., Jujoh, K., et al. (1988), Clin Immunol Immunopathol 48, 247–251.

    Article  PubMed  CAS  Google Scholar 

  54. Furukawa, S., Matsubara, T., Yone, K., Hirano, Y., Okumura, K., and Yabuta, K. (1992), Eur J Pediatr 151, 44–47.

    Article  PubMed  CAS  Google Scholar 

  55. Kim, D. S. and Lee, K. Y. (1994), Scand J Rheumatol 23, 283–286.

    PubMed  CAS  Google Scholar 

  56. Ichiyama, T., Ueno, Y., Hasegawa, M., Niimi, A., Matsubara, T., and Furukawa, S. (2004), Naunyn Schmiedebergs Arch Pharmacol 369, 428–433.

    Article  PubMed  CAS  Google Scholar 

  57. Ekberg, C., Nordstrom, E., Skansen-Saphir, U., et al. (2001), Hum Immunol 62, 215–227.

    Article  PubMed  CAS  Google Scholar 

  58. Lapointe, B. M., Herx, L. M., Gill, V., Metz, L. M., and Kubes, P. (2004), Brain 127, 2649–2656.

    Article  PubMed  Google Scholar 

  59. Takei, S., Arora, Y. K., and Walker, S. M. (1993), J Clin Invest 91, 602–607.

    PubMed  CAS  Google Scholar 

  60. Marchalonis, J. J., Kaymaz, H., Dedeoglu, F., Schluter, S. F., Yocum, D. E., and Edmundson, A. B. (1992), Proc Natl Acad. Sci USA 89, 3325–3329.

    Article  PubMed  CAS  Google Scholar 

  61. Kaveri, S., Vassilev, T., Hurez, V., et al. (1996), J Clin Invest 97, 865–889.

    PubMed  CAS  Google Scholar 

  62. Rigal, D., Vermot-Desroches, C., Heitz, S., Bernaud, J., Alfonsi, F., and Monier, J. C. (1994), Clin Immunol Immunopathol 71, 309–314.

    Article  PubMed  CAS  Google Scholar 

  63. Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., et al. (2003), Blood 101, 758–765.

    Article  PubMed  CAS  Google Scholar 

  64. Rossi, F. and Kazatchkine, M. D. (1989), J Immunol 143, 4104–4109.

    PubMed  CAS  Google Scholar 

  65. Krause, I., Blank, M., Kopolovic, J., et al. (1995), J Rheumatol 22, 1068–1074.

    PubMed  CAS  Google Scholar 

  66. Caccavo, D., Vaccaro, F., Ferri, G. M., Amoroso, A., and Bonomo, L. (1994), J Autoimmun 7, 537–548.

    Article  PubMed  CAS  Google Scholar 

  67. Wu, R., Shoenfeld, Y., Sherer, Y., et al. (2003), Autoimmunity 36, 91–97.

    Article  PubMed  CAS  Google Scholar 

  68. Sultan, Y., Kazatchkine, M. D., Maisonneuve, P., and Nydegger, U. E. (1984), Lancet 2, 765–768.

    Article  PubMed  CAS  Google Scholar 

  69. Rossi, F., Jayne, D. R., Lockwood, C. M., and Kazatchkine, M. D. (1991), Clin Exp Immunol. 83, 298–303.

    Article  PubMed  CAS  Google Scholar 

  70. Berchtold, P., Dale, G. L., Tani, P., and McMillan, R. (1989), Blood 74, 2414–2417.

    PubMed  CAS  Google Scholar 

  71. Liblau, R., Gajdos, P., Bustarret, F. A., el Habib, R., Bach, J. F., and Morel, E. (1991), J Clin Immunol 11, 128–131.

    Article  PubMed  CAS  Google Scholar 

  72. Bacchi, V. F., Maillet, F., Berlan, L., and Kazatchkine, M. D. (1992), Lancet 340, 63–64.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine B and Research Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel

    Tal Sapir & Yehuda Shoenfeld

  2. Life-Sciences Faculty, Bar-Ilan University, Ramat Gan, Israel

    Tal Sapir

  3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Yehuda Shoenfeld

  4. Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmunity Diseases, Tel Aviv University, Tel Aviv, Israel

    Yehuda Shoenfeld

Authors
  1. Tal Sapir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Shoenfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sapir, T., Shoenfeld, Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clinic Rev Allerg Immunol 29, 185–199 (2005). https://doi.org/10.1385/CRIAI:29:3:185

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:29:3:185

Index Entries

Search

Navigation